Sunshine Biopharma (SBFM) Stock Price, Quote & News

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pa...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 954 330 0684

Website: sunshinebiopharma.com

Address:

333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States

TALENT_ON_LOAN_FROM_GOD May. 18 at 3:38 PM

$SBFM UNLIMITED SUPPLY 😭😭😂

0 · Reply

topstockalerts May. 18 at 3:36 PM

$SBFM bears wanting to get trapped again

0 · Reply

cjstocksup May. 18 at 3:36 PM

$SBFM Lock up shares over $10.00 for now. This afternoon should see more epic gains above IMO to $3.00 plus today. This is why below:

0 · Reply

DayTrade_4Life May. 18 at 3:33 PM

💪So far, from the Watchlist and Alerts Today 18 May 26: 🔥Join Us to help you get the Gains. See Profile. $SBFM: 1 to 2.64 (164%) $AIM: .32 to .69 (115%) $GOVX: 2.30 to 4.92 (113%) $VRAX: .30, to .53 (76%) $CISS: 4.26 to 5.65 (32%) AIIO: $5 to 6.10 (22%) LABT: 3.50 to $4 (14%)

0 · Reply

LBTheEmcee May. 18 at 3:33 PM

$SBFM amazing bulls can’t halt it up given the amount of short shit being thrown at it

0 · Reply

MB66 May. 18 at 3:33 PM

$SBFM Check $SBFMW these are the tradeable Warrants, thinner than the stock itself.

0 · Reply

FuriousTurtle May. 18 at 3:32 PM

$SBFM bleed all day

0 · Reply

eastman71 May. 18 at 3:31 PM

$SBFM AEMD

0 · Reply

Perpar May. 18 at 3:30 PM

$SBFM 3+

0 · Reply

MB66 May. 18 at 3:30 PM

$SBFM almost 275M shares traded on an OS under 5M and we’ve moved up cents, not even dollars. What a joke. 🤡

1 · Reply

Sunshine Biopharma files to sell 5.825M common units

2026-04-06T12:53:12.000Z - 6 weeks ago

Sunshine Biopharma reports FY25 EPS ($1.44) vs. ($7.32) last year

2026-04-06T12:52:43.000Z - 6 weeks ago

Sunshine Biopharma expects to reduce expenses by $2M-$3M in 2026

Apr 6, 2026, 8:30 AM EDT - 6 weeks ago

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Oct 28, 2025, 2:10 PM EDT - 7 months ago

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

2025-10-28T11:50:45.000Z - 7 months ago

Sunshine Biopharma’s Nora Pharma receives Health Canada approval for domperidone

Oct 28, 2025, 7:45 AM EDT - 7 months ago

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

2025-10-20T11:50:37.000Z - 7 months ago

Sunshine Biopharma announces commercial launch of doxycycline in Canada

Oct 20, 2025, 7:45 AM EDT - 7 months ago

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

2025-10-16T11:50:20.000Z - 7 months ago

Sunshine Biopharma’s Nora Pharma launches pravastatin

Oct 16, 2025, 7:45 AM EDT - 7 months ago

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 14, 2025, 10:45 AM EDT - 7 months ago

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025, 8:50 AM EDT - 7 months ago

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

2025-10-14T11:20:53.000Z - 7 months ago

Sunshine Biopharma allocates $5M for investment in bitcoin

Oct 14, 2025, 7:00 AM EDT - 7 months ago

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

2025-10-09T12:26:07.000Z - 7 months ago

Sunshine Biopharma, University of Arizona develop series of protease inhibitors

Oct 9, 2025, 8:00 AM EDT - 7 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

2025-07-02T12:26:57.000Z - 11 months ago

Sunshine Biopharma’s Nora Pharma launches NIOPEG

Jul 2, 2025, 8:00 AM EDT - 11 months ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

2025-06-11T12:40:20.000Z - 1 year ago

Sunshine Biopharma launches generic gabapentin for neuropathic pain

Jun 11, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

May 15, 2025, 4:15 PM EDT - 1 year ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

2025-05-06T12:50:59.000Z - 1 year ago

Sunshine Biopharma launches generic Lurasidone for schizophrenia

May 6, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

2025-04-21T12:40:19.000Z - 1 year ago

Sunshine Biopharma launches Everolimus in Canada

Apr 21, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 3, 2025, 10:50 AM EDT - 1 year ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 2, 2025, 1:20 PM EDT - 1 year ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

2025-04-02T12:15:14.000Z - 1 year ago

Sunshine Biopharma announces results from studies on K1.1-mRNA-LNP product

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

2025-04-01T21:15:21.000Z - 1 year ago

Sunshine Biopharma reports FY24 revenue $34.9M vs $24.1M last year

Apr 1, 2025, 5:09 PM EDT - 1 year ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

2025-03-24T13:06:42.000Z - 1 year ago

Sunshine Biopharma signs agreement for rights to market two generic antibiotics

2025-03-24T12:30:07.000Z - 1 year ago

Sunshine Biopharma in strategic deal for new generic antibiotics in Canada

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

2025-03-10T13:15:30.000Z - 1 year ago

Sunshine Biopharma’s Nora Pharma acquires gastrointestinal drug rights

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Jan 21, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 15, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Dec 9, 2024, 7:30 AM EST - 1 year ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Dec 4, 2024, 4:05 PM EST - 1 year ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 2, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Nov 6, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Aug 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Aug 19, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Aug 6, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Reverse Stock Split

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Feb 15, 2024, 9:15 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Feb 13, 2024, 9:00 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Dec 4, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Moves Principal Office to New York City

Nov 13, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Sep 21, 2023, 9:05 PM EDT - 2 years ago

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Aug 11, 2023, 8:30 AM EDT - 3 years ago

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

May 16, 2023, 2:15 PM EDT - 3 years ago

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

May 16, 2023, 9:58 AM EDT - 3 years ago

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

May 12, 2023, 8:00 AM EDT - 3 years ago

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

May 11, 2023, 9:00 AM EDT - 3 years ago

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

Apr 5, 2023, 8:00 AM EDT - 3 years ago

Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update

Feb 28, 2023, 7:30 AM EST - 3 years ago

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment

Feb 10, 2023, 7:35 AM EST - 3 years ago

Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound

Jan 19, 2023, 7:30 AM EST - 3 years ago

Sunshine Biopharma Announces Share Repurchase Program

Dec 20, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma's Annual Letter to Shareholders

Dec 5, 2022, 5:46 PM EST - 3 years ago

4 Stocks Meeting GuruFocus' Value Screens in December

RM CACC WFG

Nov 16, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project

TALENT_ON_LOAN_FROM_GOD May. 18 at 3:38 PM

$SBFM UNLIMITED SUPPLY 😭😭😂

0 · Reply

topstockalerts May. 18 at 3:36 PM

$SBFM bears wanting to get trapped again

0 · Reply

cjstocksup May. 18 at 3:36 PM

$SBFM Lock up shares over $10.00 for now. This afternoon should see more epic gains above IMO to $3.00 plus today. This is why below:

0 · Reply

DayTrade_4Life May. 18 at 3:33 PM

0 · Reply

LBTheEmcee May. 18 at 3:33 PM

$SBFM amazing bulls can’t halt it up given the amount of short shit being thrown at it

0 · Reply

MB66 May. 18 at 3:33 PM

$SBFM Check $SBFMW these are the tradeable Warrants, thinner than the stock itself.

0 · Reply

FuriousTurtle May. 18 at 3:32 PM

$SBFM bleed all day

0 · Reply

eastman71 May. 18 at 3:31 PM

$SBFM AEMD

0 · Reply

Perpar May. 18 at 3:30 PM

$SBFM 3+

0 · Reply

MB66 May. 18 at 3:30 PM

$SBFM almost 275M shares traded on an OS under 5M and we’ve moved up cents, not even dollars. What a joke. 🤡

1 · Reply

LBTheEmcee May. 18 at 3:30 PM

$SBFM imagine it runs to 5

1 · Reply

Tofer85 May. 18 at 3:29 PM

$SBFM did this split this morning?

0 · Reply

CrashOutCrisp May. 18 at 3:28 PM

$AIM $SBFM $WOK $TDIC

0 · Reply

SupremeTrader93 May. 18 at 3:27 PM

$PMI just like that let’s see 30’s now 🔥🔥💪 $SBFM $VRAX $AIM $CREG 🐂🐂🎯🎯

0 · Reply

letuan7 May. 18 at 3:26 PM

$SBFM why I didn't profits when this over 2 🤣🤣 greedy man

0 · Reply

cjstocksup May. 18 at 3:26 PM

$SBFM Pay attention and do not lose shares to stop losses before the big $$$ ahead. Must read below:

0 · Reply

Trader1141 May. 18 at 3:26 PM

$SBFM $VRAX they know nothing or haven’t touched Ebola

0 · Reply

LBTheEmcee May. 18 at 3:25 PM

$SBFM holly the panic

0 · Reply

Barryman1 May. 18 at 3:25 PM

$SBFM winners: bring your gains to $VRAX 👀📈😉 Next leg up coming 210% of float short

1 · Reply

ten32 May. 18 at 3:25 PM

$SBFM GG

0 · Reply

disciplinedbull8 May. 18 at 3:24 PM

$SBFM RISING

0 · Reply

TALENT_ON_LOAN_FROM_GOD May. 18 at 3:22 PM

$SBFM IF YOU CANT TAKE PROFITS DUE TO SOME DUMB PDT RULE FROM THE 90’s …YOU ARE DISADVANTAGED. THAT ALL GOES AWAY IN JUNE. —MONEYMADE CAPICHE🤌 (IF THIS APPLIES TO YOU OF COURSE) $QUCY $TDIC $HCWB $WOK

0 · Reply

Market Cap	1.42M
Revenue (ttm)	36.31M
Net Income (ttm)	-5.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-16.47%
Debt to Equity Ratio	0.00

Volume	1,492,500
Avg Vol	99,136
Day's Range	N/A - N/A
Shares Out	5.01M
Stochastic %K	0%
Beta	1.37
Analysts	Strong Sell
Price Target	$7.00